Saxenda vs Wegovy: Which Treatment Is Right for You?
Saxenda vs Wegovy Stock Availability: No More Waiting
The difference between Saxenda and Wegovy availability in the UK has been stark over recent months. Whilst Saxenda (liraglutide) has maintained relatively stable supply, Wegovy faced significant shortages that left many patients frustrated. At EverydayMeds, we've secured reliable stock of both treatments through our established relationships with Novo Nordisk. Our current inventory includes all five Wegovy doses—from 0.25mg starter pens to 2.4mg maintenance doses—available for immediate dispatch. This means you can begin your weight management journey without the anxiety of wondering when your next dose will arrive.
Unlike other providers who may offer waitlists or uncertain delivery dates, our stock management system ensures consistent availability. We process orders within 24 hours of prescriber approval, with temperature-controlled delivery reaching you the next working day. This reliability is crucial when comparing Saxenda vs Wegovy, as treatment interruptions can affect your progress and side effect profile. Whether you choose daily Saxenda or weekly Wegovy, continuity of supply from our GPhC-registered pharmacy #9012878 gives you peace of mind to focus on your health goals.
Saxenda vs Wegovy Pricing: Complete UK Cost Comparison
When evaluating Saxenda vs Wegovy costs, the pricing structures differ significantly due to their dosing schedules. Wegovy's once-weekly injections start at £79.99 for the 0.25mg starter dose (after applying discount code FIRST40), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the maintenance 2.4mg dose. Our bundle options provide convenience for longer treatment periods—the Intro Duo combining 0.25mg and 0.5mg costs £169.99, whilst the Ultimate Stability Trio offers three months of maintenance supply at 2.4mg for £649.99. These prices reflect the final amount you pay, with discount codes applied at checkout.
Saxenda typically requires daily injections with a different cost structure, though many patients find Wegovy's weekly dosing more convenient for long-term adherence. Our pricing transparency extends to all treatment phases—new customers use code FIRST40, whilst returning patients apply DOSE25 during checkout. The investment in either treatment should be viewed alongside the comprehensive support included: clinical assessment, prescriber review, cold-chain delivery, and ongoing access to our clinical team. This complete service ensures you receive genuine, properly stored medication whether you choose Saxenda or Wegovy.
Clinical Evidence: Saxenda vs Wegovy Effectiveness
Both Saxenda and Wegovy demonstrated significant efficacy in their respective clinical programmes, though direct head-to-head comparisons aren't available due to different trial designs and populations. The STEP trials for Wegovy, particularly STEP 1 reported by Wilding et al. in the New England Journal of Medicine (2021), showed patients taking semaglutide 2.4mg alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo. The STEP 5 trial confirmed sustained results at two years, with patients maintaining approximately 15.2% weight reduction.
Saxenda's clinical evidence comes from the SCALE programme, which evaluated liraglutide 3mg daily injections in various patient populations. Both treatments work as GLP-1 receptor agonists but with different dosing frequencies and slightly different receptor binding profiles. The choice between Saxenda vs Wegovy often depends on individual patient factors, treatment history, and lifestyle preferences rather than efficacy alone, as both represent evidence-based options for weight management when used alongside a reduced-calorie diet and increased physical activity.
How Wegovy Works Compared to Saxenda
Both Saxenda and Wegovy belong to the GLP-1 receptor agonist class, mimicking the action of a natural hormone called glucagon-like peptide-1 that your intestines release after eating. When comparing Saxenda vs Wegovy mechanisms, both treatments bind to GLP-1 receptors in your brain's appetite control centres, promoting feelings of fullness and reducing food cravings between meals. The key difference lies in their pharmacokinetics—Wegovy (semaglutide) has a longer half-life allowing once-weekly dosing, whilst Saxenda (liraglutide) requires daily injections to maintain therapeutic levels. Both may help slow gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety after smaller portions. This biological approach to appetite regulation makes both treatments effective tools for weight management when combined with lifestyle modifications, though the convenience factor often influences patient preference between daily versus weekly injections.
EverydayMeds Ordering Process: Saxenda vs Wegovy Access
Accessing either Saxenda or Wegovy through EverydayMeds follows the same streamlined process, ensuring you can compare both options during your clinical assessment. The journey begins with our 3-minute online questionnaire, where you'll provide medical history, current medications, and weight management goals—our clinical team can advise on Saxenda vs Wegovy suitability based on your responses. Following submission, a qualified prescriber reviews your assessment within 3 working days (or 24 hours with express service), determining which treatment aligns with your medical profile and preferences. Once approved, we dispatch your medication via next-day delivery using temperature-controlled packaging to maintain the cold-chain integrity both treatments require. This efficient process eliminates the traditional barriers to accessing prescription weight management treatments, whether you ultimately choose daily Saxenda or weekly Wegovy injections.
Storage and Practical Considerations: Saxenda vs Wegovy
Storage requirements represent a practical consideration when choosing between Saxenda vs Wegovy, though both need refrigeration at 2-8°C before first use. Wegovy FlexTouch pens offer a travel advantage, remaining stable for up to 6 weeks at room temperature below 30°C once removed from the fridge, compared to Saxenda's shorter room temperature window. Both treatments come in pre-filled injection pens designed for subcutaneous administration into the abdomen, thigh, or upper arm, with automatic needle insertion and dose delivery mechanisms. The dose escalation schedules differ—Wegovy follows a structured 16-week titration from 0.25mg to 2.4mg, whilst Saxenda increases weekly from 0.6mg to 3mg over 4-5 weeks. Wegovy's weekly injection schedule often proves more convenient for busy lifestyles, though some patients prefer the daily routine and faster dose adjustments possible with Saxenda, making the choice between these treatments quite personal.
UK Supply Chain Reliability: Saxenda vs Wegovy Availability
The recent supply challenges affecting Wegovy availability across the UK highlighted the importance of reliable pharmaceutical partnerships and inventory management. EverydayMeds has invested significantly in securing consistent stock of both Saxenda and Wegovy through direct relationships with Novo Nordisk, the manufacturer of both treatments. Our warehouse maintains optimal storage conditions and sufficient inventory buffers to avoid the stock-outs that have affected other providers. When comparing Saxenda vs Wegovy availability, we can offer both treatments without waiting lists, ensuring patients can switch between options if needed under prescriber guidance.
This supply security becomes crucial for long-term weight management success, as treatment interruptions can affect both efficacy and side effect profiles. Our automated inventory tracking alerts us when stock levels approach reorder points, whilst our established import licenses and cold-chain logistics ensure continuous availability. Whether you prefer Saxenda's daily dosing or Wegovy's weekly convenience, our commitment to supply reliability means you can focus on your health goals rather than worrying about medication access, backed by our GPhC registration #9012878 and MHRA compliance standards.
Start Your Weight Management Journey Today
Ready to begin with either Saxenda or Wegovy? Our clinical team stands ready to help you make an informed choice between these proven treatments, both available in stock for immediate dispatch. New customers can apply discount code FIRST40 at checkout, whilst returning patients use code DOSE25 to access our competitive pricing on both Saxenda and Wegovy options. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment—our prescribers will review your individual circumstances and recommend the most suitable treatment based on your medical history, lifestyle preferences, and weight management goals. With next-day delivery and ongoing clinical support, your journey toward sustainable weight management starts with a simple online consultation, backed by the expertise and reliability that has made EverydayMeds a trusted name in UK pharmaceutical care.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
